ClinVar Genomic variation as it relates to human health
NM_003106.4(SOX2):c.70_89del (p.Asn24fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_003106.4(SOX2):c.70_89del (p.Asn24fs)
Variation ID: 94104 Accession: VCV000094104.55
- Type and length
-
Deletion, 20 bp
- Location
-
Cytogenetic: 3q26.33 3: 181712419-181712438 (GRCh38) [ NCBI UCSC ] 3: 181430207-181430226 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jun 29, 2015 Oct 20, 2024 Aug 22, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_003106.4:c.70_89del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_003097.1:p.Asn24fs frameshift NM_003106.4:c.70_89del20 MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NM_003106.3:c.70_89del20 NM_003106.3:c.70_89delAACTCCACCGCGGCGGCGGC NC_000003.12:g.181712430_181712449del NC_000003.11:g.181430218_181430237del NG_009080.1:g.5497_5516del LRG_719:g.5497_5516del - Protein change
- N24fs
- Other names
- -
- Canonical SPDI
- NC_000003.12:181712418:GCGGCGGCGGCAACTCCACCGCGGCGGCGGC:GCGGCGGCGGC
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
SOX2 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
1 | 257 | |
LOC108281177 | - | - | - | GRCh38 | - | 166 |
SOX2-OT | - | - |
GRCh38 GRCh37 |
- | 256 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Jun 10, 2022 | RCV000080064.31 | |
Pathogenic (6) |
criteria provided, multiple submitters, no conflicts
|
Aug 22, 2023 | RCV001067610.16 | |
SOX2-related disorder
|
Pathogenic (1) |
no assertion criteria provided
|
Jan 4, 2024 | RCV004549501.2 |
Pathogenic (1) |
criteria provided, single submitter
|
Jun 3, 2022 | RCV002293417.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Oct 02, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Anophthalmia/microphthalmia-esophageal atresia syndrome
Affected status: yes
Allele origin:
unknown
|
3billion
Accession: SCV002011992.1
First in ClinVar: Nov 11, 2021 Last updated: Nov 11, 2021 |
Comment:
Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported … (more)
Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant has been reported as pathogenic (PMID: 27206652, 26250054).Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Gait ataxia (present) , Spasticity (present) , Microcephaly (present) , Intellectual disability (present) , Growth delay (present) , Delayed speech and language development (present) , … (more)
Gait ataxia (present) , Spasticity (present) , Microcephaly (present) , Intellectual disability (present) , Growth delay (present) , Delayed speech and language development (present) , Short stature (present) , Cerebellar ataxia (present) , Delayed gross motor development (present) , Intellectual disability (present) (less)
|
|
Pathogenic
(Aug 25, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Anophthalmia/microphthalmia-esophageal atresia syndrome
Affected status: yes
Allele origin:
germline
|
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Accession: SCV002512420.1
First in ClinVar: May 21, 2022 Last updated: May 21, 2022 |
Comment:
ACMG classification criteria: PVS1 strong, PS4 very strong, PM2 moderate, PM6 strong
Geographic origin: Brazil
|
|
Pathogenic
(Jun 03, 2022)
|
criteria provided, single submitter
Method: research
|
Septo-optic dysplasia
Affected status: yes
Allele origin:
germline
|
Human Developmental Genetics Laboratory, Medical College of Wisconsin
Accession: SCV002538979.1
First in ClinVar: Oct 29, 2022 Last updated: Oct 29, 2022 |
Sex: male
|
|
Pathogenic
(Jun 17, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Anophthalmia/microphthalmia-esophageal atresia syndrome
Affected status: yes
Allele origin:
germline
|
MGZ Medical Genetics Center
Accession: SCV002581010.1
First in ClinVar: Oct 15, 2022 Last updated: Oct 15, 2022
Comment:
ACMG criteria applied: PVS1, PS2, PS3_MOD, PS4_MOD
|
Number of individuals with the variant: 1
|
|
Pathogenic
(Aug 22, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Anophthalmia/microphthalmia-esophageal atresia syndrome
Affected status: yes
Allele origin:
germline
|
Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
Accession: SCV004099054.1
First in ClinVar: Oct 28, 2023 Last updated: Oct 28, 2023 |
Comment:
PVS1, PS2, PS4, PM2
|
|
Pathogenic
(Nov 01, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Anophthalmia/microphthalmia-esophageal atresia syndrome
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001232678.5
First in ClinVar: Apr 15, 2020 Last updated: Feb 14, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 94104). This variant is also known … (more)
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 94104). This variant is also known as c.70del20. This premature translational stop signal has been observed in individual(s) with bilateral anophthalmia or microphthalmia with or without additional features (PMID: 18285410, 24804704, 26250054, 27206652). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn24Argfs*65) in the SOX2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 294 amino acid(s) of the SOX2 protein. (less)
|
|
Pathogenic
(Jun 10, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000566518.3
First in ClinVar: Jun 29, 2015 Last updated: Sep 16, 2024 |
Comment:
Frameshift variant in the C-terminus predicted to result in protein truncation in a gene for which loss-of-function is a known mechanism of disease; Not observed … (more)
Frameshift variant in the C-terminus predicted to result in protein truncation in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24859618, 17522144, 29371155, 24498598, 26250054, 27206652, 16283891, 16892407, 24804704, 18285410, 30450772, 30262714, 31005762, 31278258, 31884615, 33719903, 33144682, 35885948, 35170016, 16932809) (less)
|
|
Pathogenic
(Dec 01, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV002062525.20
First in ClinVar: Jan 29, 2022 Last updated: Oct 20, 2024 |
Number of individuals with the variant: 1
|
|
Pathogenic
(Mar 22, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000331496.4
First in ClinVar: Dec 06, 2016 Last updated: Jul 30, 2019 |
Number of individuals with the variant: 3
Sex: mixed
|
|
Pathogenic
(Nov 01, 2008)
|
no assertion criteria provided
Method: literature only
|
MICROPHTHALMIA, SYNDROMIC 3
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000033918.2
First in ClinVar: Apr 04, 2013 Last updated: Aug 22, 2016 |
Comment on evidence:
In an 11-month-old Mexican girl with bilateral clinical anophthalmia, mild facial dysmorphism, and developmental delay (MCOPS3; 206900), Zenteno et al. (2005) identified heterozygosity for a … (more)
In an 11-month-old Mexican girl with bilateral clinical anophthalmia, mild facial dysmorphism, and developmental delay (MCOPS3; 206900), Zenteno et al. (2005) identified heterozygosity for a 20-bp deletion at nucleotide 70 (70del20) of the SOX2 gene, resulting in a frameshift upstream of the HMG box and a premature termination signal 65 codons downstream. The authors noted that the deleted segment was flanked by the short GGCGGC repeat sequence, suggesting slipped-strand misrepairing as the origin of the deletion. In male monozygotic twins with ocular defects, esophageal atresia, and genital abnormalities, Zenteno et al. (2006) identified heterozygosity for the 70del20 mutation in the SOX2 gene. Both infants had tracheoesophageal fistula, but otherwise exhibited a discordant phenotype: 1 twin had left clinical anophthalmia and bilateral cryptorchidism, whereas the other had normal globes, narrowing of the right palpebral fissure, and no genital abnormalities. The authors stated that this was the first reported case of SOX2 mutation causing a unilateral eye defect and the first example of monozygotic twins discordant for anophthalmia. In a 22-year-old female with left clinical anophthalmia and right microphthalmia, learning difficulties, and primary amenorrhea, Kelberman et al. (2006) identified heterozygosity for a de novo 70del20 mutation in the SOX2 gene. Brain MRI revealed an abnormal hypoplastic pituitary gland in a small sella turcica with an absent left eye and optic nerve. Functional analysis of the mutant protein revealed impaired nuclear localization, DNA binding, and transcriptional activation. Kelberman et al. (2008) identified this deletion (70_89del) in a 14.5-year-old girl who presented with bilateral anophthalmia at birth. Brain MRI showed an arachnoid cyst in the suprasellar area, with right deflection of the pituitary pedunculus. She later developed gonadotropin deficiency with low basal gonadotropin concentrations and poor response to gonadotropin-releasing hormone (GNRH; 152760) stimulation. There was no evidence of learning difficulties. In a girl and 2 boys with bilateral clinical anophthalmia or severe microphthalmia, Schneider et al. (2009) identified the 70del20 mutation in the SOX2 gene. All 3 patients had developmental delay. Neuroimaging showed a hamartoma of the tuber cinereum in the 2-year-old girl, but was normal in the other 2 patients; none had pituitary anomalies. The 2 boys displayed genital anomalies, including micropenis, cryptorchidism, and foreskin adhesion. Other features seen in the 2 boys included a heart murmur in 1 patient and 2-3 toe syndactyly, febrile seizures, and mild pectus excavatum in the other. The girl had a half-sister with unilateral clinical anophthalmia and mental retardation. (less)
|
|
Pathogenic
(Jan 04, 2024)
|
no assertion criteria provided
Method: clinical testing
|
SOX2-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004710394.2
First in ClinVar: Mar 16, 2024 Last updated: Oct 08, 2024 |
Comment:
The SOX2 c.70_89del20 variant is predicted to result in a frameshift and premature protein termination (p.Asn24Argfs*65). This variant has been reported in multiple unrelated individuals … (more)
The SOX2 c.70_89del20 variant is predicted to result in a frameshift and premature protein termination (p.Asn24Argfs*65). This variant has been reported in multiple unrelated individuals with syndromic microphthalmia, and in at least 2 individuals was reported to have arisen de novo (Zenteno et al. 2005. PubMed ID: 16283891; Suzuki et al. 2014. PubMed ID: 24804704; Chacon-Camacho et al. 2015. PubMed ID: 26250054). In one individual with normal eye size, other findings included facial dysmorphisms, ocular findings (alternating esotropia, inferior oblique overaction and hyperopia), and an enlarging suprasellar lesion (Blackburn et al. 2018. PubMed ID: 30450772). This variant has not been reported in a large population database, indicating this variant is rare. Frameshift variants in SOX2 are expected to be pathogenic and this variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/94104). This variant is interpreted as pathogenic. (less)
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Novel Genetic Diagnoses in Septo-Optic Dysplasia. | Reis LM | Genes | 2022 | PMID: 35885948 |
Syndromic microphthalmia-3 caused by a mutation on gene SOX2 in a Colombian male patient. | Ramirez-Botero AF | Congenital anomalies | 2016 | PMID: 27206652 |
SOX2 anophthalmia syndrome and dental anomalies. | Chacon-Camacho OF | American journal of medical genetics. Part A | 2015 | PMID: 26250054 |
Mutation spectrum and phenotypic variation in nine patients with SOX2 abnormalities. | Suzuki J | Journal of human genetics | 2014 | PMID: 24804704 |
Familial recurrence of SOX2 anophthalmia syndrome: phenotypically normal mother with two affected daughters. | Schneider A | American journal of medical genetics. Part A | 2008 | PMID: 18831064 |
SOX2 plays a critical role in the pituitary, forebrain, and eye during human embryonic development. | Kelberman D | The Journal of clinical endocrinology and metabolism | 2008 | PMID: 18285410 |
Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. | Kelberman D | The Journal of clinical investigation | 2006 | PMID: 16932809 |
Anophthalmia-esophageal atresia syndrome caused by an SOX2 gene deletion in monozygotic twin brothers with markedly discordant phenotypes. | Zenteno JC | American journal of medical genetics. Part A | 2006 | PMID: 16892407 |
Bilateral anophthalmia and brain malformations caused by a 20-bp deletion in the SOX2 gene. | Zenteno JC | Clinical genetics | 2005 | PMID: 16283891 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SOX2 | - | - | - | - |
Text-mined citations for rs398123693 ...
HelpRecord last updated Nov 10, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.